在实验性自身免疫性脑脊髓炎中，抗炎和神经保护药物联合治疗的附加效应。
Additive effects of combination treatment with anti-inflammatory and neuroprotective agents in experimental autoimmune encephalomyelitis.
机构信息
University of California, Los Angeles, Department of Neurology, UCLA Multiple Sclerosis Program, 635 Charles E Young Drive South, Neuroscience Research Building 1, Room 479, Los Angeles, CA 90095, United States.
出版信息
J Neuroimmunol. 2010 Feb 26;219(1-2):64-74. doi: 10.1016/j.jneuroim.2009.11.018. Epub 2009 Dec 14.
Abstract
We studied the effects of combination treatment with an anti-inflammatory agent, interferon (IFN)-beta, and a putative neuroprotective agent, an estrogen receptor (ER)-beta ligand, during EAE. Combination treatment significantly attenuated EAE disease severity, preserved axonal densities in spinal cord, and reduced CNS inflammation. Combining ERbeta treatment with IFNbeta reduced IL-17, while it abrogated IFNbeta-mediated increases in Th1 and Th2 cytokines from splenocytes. Additionally, combination treatment reduced VLA-4 expression on CD4+ T cells, while it abrogated IFNbeta-mediated decreases in MMP-9. Our data demonstrate that combination treatments can result in complex effects that could not have been predicted based on monotherapy data alone.
摘要
我们研究了在 EAE 期间联合使用抗炎药干扰素 (IFN)-β和一种假定的神经保护剂雌激素受体 (ER)-β配体的治疗效果。联合治疗显著减轻了 EAE 的严重程度，保留了脊髓中的轴突密度，并减少了中枢神经系统的炎症。将 ERβ治疗与 IFNβ 联合使用可减少 IL-17，同时消除了 IFNβ 介导的脾细胞 Th1 和 Th2 细胞因子的增加。此外，联合治疗降低了 CD4+T 细胞上的 VLA-4 表达，同时消除了 IFNβ 介导的 MMP-9 减少。我们的数据表明，联合治疗可能会产生复杂的效果，这些效果不能仅根据单药治疗数据来预测。
相似文献
1
Additive effects of combination treatment with anti-inflammatory and neuroprotective agents in experimental autoimmune encephalomyelitis.在实验性自身免疫性脑脊髓炎中，抗炎和神经保护药物联合治疗的附加效应。
J Neuroimmunol. 2010 Feb 26;219(1-2):64-74. doi: 10.1016/j.jneuroim.2009.11.018. Epub 2009 Dec 14.
2
Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis.用雌激素受体α配体进行治疗在实验性自身免疫性脑脊髓炎中具有神经保护作用。
J Neurosci. 2006 Jun 21;26(25):6823-33. doi: 10.1523/JNEUROSCI.0453-06.2006.
3
Estrogen receptor-β ligand treatment after disease onset is neuroprotective in the multiple sclerosis model.雌激素受体-β配体治疗疾病发作后对多发性硬化模型具有神经保护作用。
J Neurosci Res. 2013 Jul;91(7):901-8. doi: 10.1002/jnr.23219. Epub 2013 Apr 30.
4
The effect of calcitriol and all-trans retinoic acid on T-bet, IFN-γ, GATA3 and IL-4 genes expression in experimental autoimmune encephalomyelitis.骨化三醇和全反式维 A 酸对实验性自身免疫性脑脊髓炎中 T-bet、IFN-γ、GATA3 和 IL-4 基因表达的影响。
APMIS. 2020 Nov;128(11):583-592. doi: 10.1111/apm.13073. Epub 2020 Sep 26.
5
Role of orexin-A in experimental autoimmune encephalomyelitis.食欲素A在实验性自身免疫性脑脊髓炎中的作用。
J Neuroimmunol. 2016 Feb 15;291:101-9. doi: 10.1016/j.jneuroim.2016.01.001. Epub 2016 Jan 8.
6
Low dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cord.低剂量右美沙芬通过抑制 NOX2 和减少脊髓外周免疫细胞浸润来减轻中度实验性自身免疫性脑脊髓炎。
Neurobiol Dis. 2011 Oct;44(1):63-72. doi: 10.1016/j.nbd.2011.06.004. Epub 2011 Jun 24.
7
Ulinastatin attenuates experimental autoimmune encephalomyelitis by enhancing anti-inflammatory responses.乌司他丁通过增强抗炎反应减轻实验性自身免疫性脑脊髓炎。
Neurochem Int. 2014 Jan;64:64-72. doi: 10.1016/j.neuint.2013.11.007. Epub 2013 Nov 22.
8
Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.系统给予食欲素 A 可通过减轻神经炎症改善实验性自身免疫性脑脊髓炎。
J Neuroinflammation. 2019 Mar 20;16(1):64. doi: 10.1186/s12974-019-1447-y.
9
Oestrogen receptor β ligand acts on CD11c+ cells to mediate protection in experimental autoimmune encephalomyelitis.雌激素受体β配体通过作用于 CD11c+细胞来介导实验性自身免疫性脑脊髓炎的保护作用。
Brain. 2018 Jan 1;141(1):132-147. doi: 10.1093/brain/awx315.
10
Targeted GAS6 delivery to the CNS protects axons from damage during experimental autoimmune encephalomyelitis.在实验性自身免疫性脑脊髓炎期间，将GAS6靶向递送至中枢神经系统可保护轴突免受损伤。
J Neurosci. 2014 Dec 3;34(49):16320-35. doi: 10.1523/JNEUROSCI.2449-14.2014.
引用本文的文献
1
XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis.性染色体 XY 复合物与 XX 相比，在中枢神经系统中会导致实验性自身免疫性脑脊髓炎期间更大程度的神经退行性变。
Proc Natl Acad Sci U S A. 2014 Feb 18;111(7):2806-11. doi: 10.1073/pnas.1307091111. Epub 2014 Feb 3.
2
Estrogen receptor (ER) β expression in oligodendrocytes is required for attenuation of clinical disease by an ERβ ligand.少突胶质细胞中雌激素受体 β 的表达对于雌激素受体 β 配体减轻临床疾病是必需的。
Proc Natl Acad Sci U S A. 2013 Nov 19;110(47):19125-30. doi: 10.1073/pnas.1311763110. Epub 2013 Nov 4.
3
Estrogen receptor-β ligand treatment after disease onset is neuroprotective in the multiple sclerosis model.雌激素受体-β配体治疗疾病发作后对多发性硬化模型具有神经保护作用。
J Neurosci Res. 2013 Jul;91(7):901-8. doi: 10.1002/jnr.23219. Epub 2013 Apr 30.
4
Sex-related factors in multiple sclerosis susceptibility and progression.多发性硬化症易感性和进展中的性别相关因素。
Nat Rev Neurol. 2012 Mar 27;8(5):255-63. doi: 10.1038/nrneurol.2012.43.
5
Neuroprotective effects of estrogens and androgens in CNS inflammation and neurodegeneration.雌激素和雄激素对中枢神经系统炎症和神经退行性变的神经保护作用。
Front Neuroendocrinol. 2012 Jan;33(1):105-15. doi: 10.1016/j.yfrne.2011.12.001. Epub 2011 Dec 24.
6
Development of subtype-selective oestrogen receptor-based therapeutics.基于亚型选择性雌激素受体的治疗药物的研发。
Nat Rev Drug Discov. 2011 Sep 16;10(10):778-92. doi: 10.1038/nrd3551.
7
Sex differences in autoimmune diseases.自身免疫性疾病中的性别差异。
Biol Sex Differ. 2011 Jan 4;2(1):1. doi: 10.1186/2042-6410-2-1.
8
Oestrogen receptor beta ligand: a novel treatment to enhance endogenous functional remyelination.雌激素受体β配体：一种促进内源性功能性髓鞘再生的新型治疗方法。
Brain. 2010 Oct;133(10):2999-3016. doi: 10.1093/brain/awq237. Epub 2010 Sep 21.
本文引用的文献
1
Oestrogen modulates experimental autoimmune encephalomyelitis and interleukin-17 production via programmed death 1.雌激素通过程序性死亡1调节实验性自身免疫性脑脊髓炎和白细胞介素-17的产生。
Immunology. 2009 Mar;126(3):329-35. doi: 10.1111/j.1365-2567.2008.03051.x.
2
Membrane estrogen receptor regulates experimental autoimmune encephalomyelitis through up-regulation of programmed death 1.膜雌激素受体通过上调程序性死亡蛋白1来调节实验性自身免疫性脑脊髓炎。
J Immunol. 2009 Mar 1;182(5):3294-303. doi: 10.4049/jimmunol.0803205.
3
Effect of natalizumab on clinical and radiological disease activity in multiple sclerosis: a retrospective analysis of the Natalizumab Safety and Efficacy in Relapsing-Remitting Multiple Sclerosis (AFFIRM) study.那他珠单抗对多发性硬化症临床及影像学疾病活动的影响：复发缓解型多发性硬化症那他珠单抗安全性与疗效（AFFIRM）研究的回顾性分析
Lancet Neurol. 2009 Mar;8(3):254-60. doi: 10.1016/S1474-4422(09)70021-3. Epub 2009 Feb 7.
4
Beta1 integrins differentially control extravasation of inflammatory cell subsets into the CNS during autoimmunity.β1整合素在自身免疫过程中对炎症细胞亚群渗入中枢神经系统具有不同的调控作用。
Proc Natl Acad Sci U S A. 2009 Feb 10;106(6):1920-5. doi: 10.1073/pnas.0808909106. Epub 2009 Jan 28.
5
Changes in matrix metalloproteinases and their inhibitors during interferon-beta treatment in multiple sclerosis.多发性硬化症患者在β-干扰素治疗期间基质金属蛋白酶及其抑制剂的变化
Clin Immunol. 2009 Feb;130(2):145-50. doi: 10.1016/j.clim.2008.09.010. Epub 2008 Oct 21.
6
IL-23 promotes maintenance but not commitment to the Th17 lineage.白细胞介素-23促进Th17细胞系的维持，但不促进其分化。
J Immunol. 2008 Nov 1;181(9):5948-55. doi: 10.4049/jimmunol.181.9.5948.
7
Beta interferon restricts the inflammatory potential of CD4+ cells through the boost of the Th2 phenotype, the inhibition of Th17 response and the prevalence of naturally occurring T regulatory cells.β干扰素通过增强Th2表型、抑制Th17反应以及使自然产生的调节性T细胞占优势来限制CD4+细胞的炎症潜能。
Mol Immunol. 2008 Sep;45(15):4008-19. doi: 10.1016/j.molimm.2008.06.006. Epub 2008 Jul 18.
8
Engagement of the type I interferon receptor on dendritic cells inhibits T helper 17 cell development: role of intracellular osteopontin.树突状细胞上I型干扰素受体的激活抑制辅助性T细胞17的发育：细胞内骨桥蛋白的作用
Immunity. 2008 Jul 18;29(1):68-78. doi: 10.1016/j.immuni.2008.05.008.
9
Type 1 interferons cool the inflamed brain.1型干扰素使发炎的大脑降温。
Immunity. 2008 May;28(5):600-2. doi: 10.1016/j.immuni.2008.04.006.
10
Distinct and nonredundant in vivo functions of IFNAR on myeloid cells limit autoimmunity in the central nervous system.IFNAR在髓样细胞上独特且非冗余的体内功能限制了中枢神经系统中的自身免疫。
Immunity. 2008 May;28(5):675-86. doi: 10.1016/j.immuni.2008.03.011.
Zotero 插件